Innovator IBD Financials
| FFTY Etf | USD 29.84 0.67 2.30% |
Net Expense Ratio 0.008 | 3 y Sharp Ratio (0.43) |
Innovator |
The data published in Innovator IBD's official financial statements typically reflect Innovator IBD's business processes, product offerings, services, and other fundamental events. However, there are additional fundamental indicators that are easier to understand and visualize along the underlying realities that are driving Innovator IBD's quantitative information. For example, before you start analyzing numbers published by Innovator accountants, it's essential to understand Innovator IBD's liquidity, profitability, and earnings quality within the context of the Innovator ETFs space in which it operates.
Please note, the imprecision that can be found in Innovator IBD's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Innovator IBD 50. Check Innovator IBD's Beneish M Score to see the likelihood of Innovator IBD's management manipulating its earnings.
Innovator IBD Etf Summary
Innovator IBD competes with Invesco NASDAQ, WisdomTree Cloud, Global X, and ARK Fintech. The fund will normally invest at least 80 percent of its net assets in securities that comprise the index. Innovator Ibd is traded on NYSEARCA Exchange in the United States.| Instrument | USA Etf View All |
| Exchange | NYSE ARCA Exchange |
| ISIN | US45782C1027 |
| CUSIP | 45782C102 004006508 |
| Region | Global |
| Investment Issuer | Innovator Capital Management |
| Etf Family | Innovator ETFs |
| Fund Category | Broad Equity |
| Portfolio Concentration | Strategy |
| Benchmark | Dow Jones Industrial |
| Website | innovatorfunds.com/fundetf.php |
| Phone | NA |
| Currency | USD - US Dollar |
Innovator IBD Key Financial Ratios
Innovator Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Innovator IBD's current stock value. Our valuation model uses many indicators to compare Innovator IBD value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Innovator IBD competition to find correlations between indicators driving Innovator IBD's intrinsic value. More Info.Innovator IBD 50 is one of the top ETFs in price to earning as compared to similar ETFs. It also is one of the top ETFs in price to book as compared to similar ETFs fabricating about 0.15 of Price To Book per Price To Earning. The ratio of Price To Earning to Price To Book for Innovator IBD 50 is roughly 6.55 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Innovator IBD's earnings, one of the primary drivers of an investment's value.Innovator IBD 50 Systematic Risk
Innovator IBD's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Innovator IBD volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
Incorrect Input. Please change your parameters or increase the time horizon required for running this function. The output start index for this execution was zero with a total number of output elements of zero. The Beta measures systematic risk based on how returns on Innovator IBD 50 correlated with the market. If Beta is less than 0 Innovator IBD generally moves in the opposite direction as compared to the market. If Innovator IBD Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Innovator IBD 50 is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Innovator IBD is generally in the same direction as the market. If Beta > 1 Innovator IBD moves generally in the same direction as, but more than the movement of the benchmark.
Steps to analyze company Financials for Investing
There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as Innovator IBD is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of Innovator has grown by more than 25% over the last five years, then there is a good chance that it will continue growing by at least 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it. In summary, you can determine if Innovator IBD's financials are consistent with your investment objective using the following steps:- Review Innovator IBD's balance sheet accounts, such as liabilities and equity, to understand its overall financial position.
- Analyze the income statement and examine the company's revenue, expenses, and profits over time to determine its financial performance.
- Study the cash flow inflows and outflows to understand Innovator IBD's liquidity and solvency.
- Look at the growth rates in revenue, earnings, and cash flow over time to determine its potential for future growth.
- Compare Innovator IBD's financials to those of its peers to see how it stacks up and identify any potential red flags.
- Use valuation ratios to evaluate the company's financials using commonly used ratios such as the price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and enterprise value-to-earnings before interest, taxes, depreciation, and amortization (EV/EBITDA) ratio to determine if Innovator IBD's stock is overvalued or undervalued.
Innovator IBD Thematic Clasifications
Innovator IBD 50 is part of several thematic ideas from Strategy ETFs to Broad Equity ETFs. If you are a theme-oriented, socially responsible, and at the same time, a result-driven investor, you can align your investing habits with your values without jeopardizing your expectations about returns. You can easily create an optimal portfolio of stocks, ETFs, funds, or cryptocurrencies based on a specific theme of your liking. Get More Thematic IdeasInnovator IBD December 22, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Innovator IBD help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Innovator IBD 50. We use our internally-developed statistical techniques to arrive at the intrinsic value of Innovator IBD 50 based on widely used predictive technical indicators. In general, we focus on analyzing Innovator Etf price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Innovator IBD's daily price indicators and compare them against related drivers.
| Downside Deviation | 1.78 | |||
| Information Ratio | 0.0766 | |||
| Maximum Drawdown | 11.25 | |||
| Value At Risk | (2.05) | |||
| Potential Upside | 3.15 |
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Innovator IBD 50. Also, note that the market value of any etf could be closely tied with the direction of predictive economic indicators such as signals in estimate. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
The market value of Innovator IBD 50 is measured differently than its book value, which is the value of Innovator that is recorded on the company's balance sheet. Investors also form their own opinion of Innovator IBD's value that differs from its market value or its book value, called intrinsic value, which is Innovator IBD's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Innovator IBD's market value can be influenced by many factors that don't directly affect Innovator IBD's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Innovator IBD's value and its price as these two are different measures arrived at by different means. Investors typically determine if Innovator IBD is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Innovator IBD's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.